Cargando…

Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus

Aims/Introduction:  Although the improvement of postprandial hyperglycemia by an alpha‐glucosidase inhibitor (α‐GI) has been associated with a risk reduction of cardiovascular events, the relationship between postprandial hyperglycemia and arterial stiffness has not been well understood. We therefor...

Descripción completa

Detalles Bibliográficos
Autores principales: Uzui, Hiroyasu, Nakano, Akira, Mitsuke, Yasuhiko, Geshi, Toru, Sakata, Junji, Sarazawa, Katsuhiko, Morishita, Tetsuji, Satou, Takehiko, Ishida, Kentarou, Lee, Jong‐Dae
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015543/
https://www.ncbi.nlm.nih.gov/pubmed/24843474
http://dx.doi.org/10.1111/j.2040-1124.2010.00079.x
_version_ 1782315353192267776
author Uzui, Hiroyasu
Nakano, Akira
Mitsuke, Yasuhiko
Geshi, Toru
Sakata, Junji
Sarazawa, Katsuhiko
Morishita, Tetsuji
Satou, Takehiko
Ishida, Kentarou
Lee, Jong‐Dae
author_facet Uzui, Hiroyasu
Nakano, Akira
Mitsuke, Yasuhiko
Geshi, Toru
Sakata, Junji
Sarazawa, Katsuhiko
Morishita, Tetsuji
Satou, Takehiko
Ishida, Kentarou
Lee, Jong‐Dae
author_sort Uzui, Hiroyasu
collection PubMed
description Aims/Introduction:  Although the improvement of postprandial hyperglycemia by an alpha‐glucosidase inhibitor (α‐GI) has been associated with a risk reduction of cardiovascular events, the relationship between postprandial hyperglycemia and arterial stiffness has not been well understood. We therefore examined whether ameliorating the postprandial state by α‐GI leads to an improvement in arterial stiffness. Materials and Methods:  A total of 22 patients with type 2 diabetes mellitus were treated with acarbose. Cardio‐ankle vascular index (CAVI) as the arterial stiffness was measured by using a VaSera CAVI instrument before and 12 months after acarbose treatment. Serum high‐sensitivity C‐reactive protein (hs‐CRP), pentraxin‐3 (PTX3) and matrix metalloproteinase (MMP) ‐2, ‐9 were measured at the same time points. Furthermore, circulating peripheral blood mononuclear cells were examined for the frequencies of CD14 positive cells expressing membrane type‐1 MMP (MT1‐MMP) at the single cell level using flow cytometry. Results:  After acarbose treatment, postprandial glucose and glycosylated hemoglobin (HbA(1c)) were significantly decreased. Serum levels of hs‐CRP, PTX3, MMP‐2 and MMP‐9 were significantly decreased. CAVI showed a significant reduction, although the changes were not significant in blood pressure and heart rate. MT1‐MMP expression was significantly decreased by acarbose treatment. In multivariate analysis, improvement of blood glucose, decrease of PTX3 levels and MT1‐MMP expression were independent predictors of beneficial change in CAVI. Conclusions:  The present study showed that the beneficial effects of acarbose on arterial stiffness are mediated by an improvement of postprandial hyperglycemia and vascular remodeling markers. In conclusion, acarbose treatment might reduce the risk of cardiovascular diseases by altering the arterial stiffness in postprandial hyperglycemic status. (J Diabetes Invest, doi:10.1111/j.2040‐1124.2010.00079.x, 2010)
format Online
Article
Text
id pubmed-4015543
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-40155432014-05-19 Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus Uzui, Hiroyasu Nakano, Akira Mitsuke, Yasuhiko Geshi, Toru Sakata, Junji Sarazawa, Katsuhiko Morishita, Tetsuji Satou, Takehiko Ishida, Kentarou Lee, Jong‐Dae J Diabetes Investig Articles Aims/Introduction:  Although the improvement of postprandial hyperglycemia by an alpha‐glucosidase inhibitor (α‐GI) has been associated with a risk reduction of cardiovascular events, the relationship between postprandial hyperglycemia and arterial stiffness has not been well understood. We therefore examined whether ameliorating the postprandial state by α‐GI leads to an improvement in arterial stiffness. Materials and Methods:  A total of 22 patients with type 2 diabetes mellitus were treated with acarbose. Cardio‐ankle vascular index (CAVI) as the arterial stiffness was measured by using a VaSera CAVI instrument before and 12 months after acarbose treatment. Serum high‐sensitivity C‐reactive protein (hs‐CRP), pentraxin‐3 (PTX3) and matrix metalloproteinase (MMP) ‐2, ‐9 were measured at the same time points. Furthermore, circulating peripheral blood mononuclear cells were examined for the frequencies of CD14 positive cells expressing membrane type‐1 MMP (MT1‐MMP) at the single cell level using flow cytometry. Results:  After acarbose treatment, postprandial glucose and glycosylated hemoglobin (HbA(1c)) were significantly decreased. Serum levels of hs‐CRP, PTX3, MMP‐2 and MMP‐9 were significantly decreased. CAVI showed a significant reduction, although the changes were not significant in blood pressure and heart rate. MT1‐MMP expression was significantly decreased by acarbose treatment. In multivariate analysis, improvement of blood glucose, decrease of PTX3 levels and MT1‐MMP expression were independent predictors of beneficial change in CAVI. Conclusions:  The present study showed that the beneficial effects of acarbose on arterial stiffness are mediated by an improvement of postprandial hyperglycemia and vascular remodeling markers. In conclusion, acarbose treatment might reduce the risk of cardiovascular diseases by altering the arterial stiffness in postprandial hyperglycemic status. (J Diabetes Invest, doi:10.1111/j.2040‐1124.2010.00079.x, 2010) Blackwell Publishing Ltd 2011-04-07 2010-11-03 /pmc/articles/PMC4015543/ /pubmed/24843474 http://dx.doi.org/10.1111/j.2040-1124.2010.00079.x Text en © 2010 Asian Association for the Study of Diabetes and Blackwell Publishing Asia Pty Ltd
spellingShingle Articles
Uzui, Hiroyasu
Nakano, Akira
Mitsuke, Yasuhiko
Geshi, Toru
Sakata, Junji
Sarazawa, Katsuhiko
Morishita, Tetsuji
Satou, Takehiko
Ishida, Kentarou
Lee, Jong‐Dae
Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
title Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
title_full Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
title_fullStr Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
title_full_unstemmed Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
title_short Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
title_sort acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4015543/
https://www.ncbi.nlm.nih.gov/pubmed/24843474
http://dx.doi.org/10.1111/j.2040-1124.2010.00079.x
work_keys_str_mv AT uzuihiroyasu acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus
AT nakanoakira acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus
AT mitsukeyasuhiko acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus
AT geshitoru acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus
AT sakatajunji acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus
AT sarazawakatsuhiko acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus
AT morishitatetsuji acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus
AT satoutakehiko acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus
AT ishidakentarou acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus
AT leejongdae acarbosetreatmentsimprovearterialstiffnessinpatientswithtype2diabetesmellitus